Sarepta Therapeutics (Brazil) Price on October 10, 2024
S1RP34 Stock | BRL 40.08 0.39 0.96% |
If you're considering investing in Sarepta Stock, it is important to understand the factors that can impact its price. As of today, the current price of Sarepta Therapeutics stands at 40.08, as last reported on the 4th of December, with the highest price reaching 40.88 and the lowest price hitting 40.08 during the day. At this point, Sarepta Therapeutics is not too volatile. Sarepta Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0491, which indicates the firm had a 0.0491% return per unit of risk over the last 3 months. We have found thirty technical indicators for Sarepta Therapeutics, which you can use to evaluate the volatility of the company. Please validate Sarepta Therapeutics' Coefficient Of Variation of 3199.95, semi deviation of 1.84, and Risk Adjusted Performance of 0.0316 to confirm if the risk estimate we provide is consistent with the expected return of 0.17%.
Sarepta Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Sarepta |
Sharpe Ratio = 0.0491
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | S1RP34 | |||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
3.43 actual daily | 30 70% of assets are more volatile |
Expected Return
0.17 actual daily | 3 97% of assets have higher returns |
Risk-Adjusted Return
0.05 actual daily | 3 97% of assets perform better |
Based on monthly moving average Sarepta Therapeutics is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Sarepta Therapeutics by adding it to a well-diversified portfolio.
Sarepta Therapeutics Valuation on October 10, 2024
It is possible to determine the worth of Sarepta Therapeutics on a given historical date. On October 10, 2024 Sarepta was worth 33.83 at the beginning of the trading date compared to the closed value of 33.78. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Sarepta Therapeutics stock. Still, in general, we apply an absolute valuation method to find Sarepta Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Sarepta Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Sarepta Therapeutics' related companies.
Open | High | Low | Close | Volume | |
32.82 | 32.88 | 32.67 | 32.67 | 1,806 | |
10/10/2024 | 33.83 | 34.50 | 33.78 | 33.78 | 11.00 |
34.67 | 35.18 | 34.67 | 35.18 | 6.00 |
Backtest Sarepta Therapeutics | | | Sarepta Therapeutics History | | | Sarepta Therapeutics Valuation | Previous | Next |
Sarepta Therapeutics Trading Date Momentum on October 10, 2024
On October 11 2024 Sarepta Therapeutics was traded for 35.18 at the closing time. The highest price during the trading period was 35.18 and the lowest recorded bid was listed for 34.67 . The volume for the day was 6.0. This history from October 11, 2024 contributed to the next trading day price jump. The trading price change to the next closing price was 4.14% . The trading price change to the current price is 10.48% . |
Sarepta Therapeutics Fundamentals Correlations and Trends
By evaluating Sarepta Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Sarepta Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Sarepta financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Sarepta Therapeutics Stock history
Sarepta Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Sarepta is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Sarepta Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Sarepta Therapeutics stock prices may prove useful in developing a viable investing in Sarepta Therapeutics
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. Sarepta Therapeutics, Inc. was incorporated in 1980 and is headquartered in Cambridge, Massachusetts. SAREPTA THERDRN operates under Biotechnology classification in Brazil and is traded on Sao Paolo Stock Exchange. It employs 866 people.
Sarepta Therapeutics Stock Technical Analysis
Sarepta Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Sarepta Therapeutics Period Price Range
Low | December 4, 2024
| High |
0.00 | 0.00 |
Sarepta Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on Sao Paulo Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Sarepta Therapeutics December 4, 2024 Market Strength
Market strength indicators help investors to evaluate how Sarepta Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Sarepta Therapeutics shares will generate the highest return on investment. By undertsting and applying Sarepta Therapeutics stock market strength indicators, traders can identify Sarepta Therapeutics entry and exit signals to maximize returns
Sarepta Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Sarepta Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Sarepta Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Sarepta to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0316 | |||
Jensen Alpha | 0.0951 | |||
Total Risk Alpha | (0.36) | |||
Sortino Ratio | (0) | |||
Treynor Ratio | (16.01) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Complementary Tools for Sarepta Stock analysis
When running Sarepta Therapeutics' price analysis, check to measure Sarepta Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sarepta Therapeutics is operating at the current time. Most of Sarepta Therapeutics' value examination focuses on studying past and present price action to predict the probability of Sarepta Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sarepta Therapeutics' price. Additionally, you may evaluate how the addition of Sarepta Therapeutics to your portfolios can decrease your overall portfolio volatility.
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |